PDE7A/CRE Reporter - HEK293 Recombinant Cell Line

PDE7A/CRE Reporter - HEK293 Recombinant Cell Line
Artikelnummer
BPS60413
Verpackungseinheit
2 vials
Hersteller
BPS Bioscience

Verfügbarkeit: wird geladen...
Preis wird geladen...
Products from BPS Bioscience require a minimum order value above 400€

Applications: Monitor Thuman PDE7A activityScreen for activators or inhibitors of PDE7A

Biological Activity: The cell line is validated for the induction of the expression of luciferase reporter by an inhibitor of PDE7A.

Description: The PDE7A/CRE Reporter-HEK293 line contains the firefly luciferase gene under the control of CRE as well as a constitutive expression construct for human PDE7A (phosphodiesterase 7A, accession number NM_002603), both stably integrated into HEK293 cells. The luciferase expression level from the CRE reporter is used to monitor the activity of PDE7A in the cells.

Genbank: NM_002603

Host Cell Line: HEK293

Mycoplasma Testing: The cell line has been screened using the PCR-based Venor™GeM Mycoplasma Detection kit (Sigma Aldrich) to confirm the absence of Mycoplasma species.

Storage Stability: Store in liquid nitrogen immediately upon receipt.

Supplied As: Each vial contains ~ X 10^6 cells in 1 ml of 10% DMSO.

Warnings: Avoid freeze/thaw cycles.

Biosafety Level: BSL-2

References: 1. Malik, R. et al. (2008) Cloning, stable expression of human phosphodiesterase 7A and development of an assay for screening of PDE7 selective inhibitors. Appl. Microbiol. Biotechnol. 77 (5): 1167-1173.2. Fan Chung, K. (2006) Phosphodiesterase inhibitors in airways disease. Eur. J. Pharmacol. 533(1-3):110-117.
Mehr Informationen
Artikelnummer BPS60413
Hersteller BPS Bioscience
Hersteller Artikelnummer 60413
Verpackungseinheit 2 vials
Mengeneinheit PAK
Wirt Human
Produktinformation (PDF) Download
MSDS (PDF)
×